| Identification | Back Directory | [Name]
PD 173952 | [CAS]
305820-75-1 | [Synonyms]
PD 173952
6-(2,6-dichlorophenyl)-8-methyl-2-(4-morpholin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one
6-(2,6-Dichlorophenyl)-8-methyl-2-((4-morpholinophenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
6-(2,6-Dichloro-phenyl)-8-Methyl-2-(4-Morpholin-4-yl-phenylaMino)-8H-pyrido[2,3-d]pyriMidin-7-one
6-(2,6-Dichlorophenyl)-8-Methyl-2-[[4-(4-Morpholinyl)phenyl]aMino]pyrido[2,3-d]pyriMidin-7(8H)-one
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-(2,6-dichlorophenyl)-8-methyl-2-[[4-(4-morpholinyl)phenyl]amino]- | [Molecular Formula]
C24H21Cl2N5O2 | [MDL Number]
MFCD16875428 | [MOL File]
305820-75-1.mol | [Molecular Weight]
482.36 |
| Chemical Properties | Back Directory | [Melting point ]
>280oC (dec.) | [Boiling point ]
693.0±65.0 °C(Predicted) | [density ]
1.422±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO: >10mg/mL | [form ]
powder | [pka]
5.79±0.40(Predicted) | [color ]
yellow to green | [InChI]
1S/C24H21Cl2N5O2/c1-30-22-15(13-18(23(30)32)21-19(25)3-2-4-20(21)26)14-27-24(29-22)28-16-5-7-17(8-6-16)31-9-11-33-12-10-31/h2-8,13-14H,9-12H2,1H3,(H,27,28,29) | [InChIKey]
XZEJMVDCQZRHLN-UHFFFAOYSA-N | [SMILES]
CN1C(=O)C(=Cc2cnc(Nc3ccc(cc3)N4CCOCC4)nc12)c5c(Cl)cccc5Cl |
| Hazard Information | Back Directory | [Chemical Properties]
Green Solid | [Uses]
As a Bcr-Abl tyrosine kinase inhibitor, 6-(2,6-dichlorophenyl)-8-methyl-2-(4-morpholin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one can be used in treatment research for chronic myelegenous leukemia (CML). | [Uses]
PD-173952 is a Bcr-Abl tyrosine kinase inhibitor used in treatment research for chronic myelegenous leukemia (CML). | [Biological Activity]
PD173952 is a Src family kinase inhibitor. | [IC 50]
Lyn: 0.3 nM (IC50); Abl: 1.7 nM (IC50); Csk: 6.6 nM (IC50); Myt1: 8.1 nM (Ki); PKMYT1 |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|